Enkephalinase
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by OAbot (talk | contribs) at 02:44, 17 April 2020 (Open access bot: doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 02:44, 17 April 2020 by OAbot (talk | contribs) (Open access bot: doi added to citation with #oabot.)
Enkephalinases are enzymes that degrade endogenous enkephalin opioid peptides. They include:
- Aminopeptidase N (APN)[1]
- Neutral endopeptidase (NEP)[1]
- Dipeptidyl peptidase 3 (DPP3)[1]
- Carboxypeptidase A6 (CPA6)[2]
- Leucyl/cystinyl aminopeptidase (LNPEP)
- Angiotensin-converting enzyme (ACE)[3]
See also
References
- ^ a b c Thanawala V, Kadam VJ, Ghosh R (October 2008). "Enkephalinase inhibitors: potential agents for the management of pain". Current Drug Targets. 9 (10): 887–94. doi:10.2174/138945008785909356. PMID 18855623.[permanent dead link]
- ^ Lyons PJ, Callaway MB, Fricker LD (March 2008). "Characterization of carboxypeptidase A6, an extracellular matrix peptidase". The Journal of Biological Chemistry. 283 (11): 7054–63. doi:10.1074/jbc.M707680200. PMID 18178555.
- ^ Benuck M, Berg MJ, Marks N (1982). "Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes". Neurochemistry International. 4 (5): 389–96. doi:10.1016/0197-0186(82)90081-X. PMID 20487892.
| 3.4.11-19: Exopeptidase |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.4.21-25: Endopeptidase | |||||||||||||||
| 3.4.99: Unknown | |||||||||||||||
